SuperworthBlack Diamond Therapeutics market cap BDTX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $108M
- Highest close in our data
- $1.5B
- May 2020
Black Diamond Therapeutics is worth $108M at the close on Oct 23, 2026, at $1.88 a share.
That is down 52% over the last year and down 61% over five years.
Its highest close in our data was $1.5B in May 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $108M | $95.1M | $175.3M | −27% |
| 2025 | $147.6M | $78.8M | $232.9M | +19% |
| 2024 | $123.9M | $123.9M | $365M | −15% |
| 2023 | $145.1M | $49.2M | $184.4M | +122% |
| 2022 | $65.5M | $46.2M | $184.8M | −66% |
| 2021 | $193.1M | $187.7M | $1.2B | −83% |
| 2020 | $1.2B | $854.7M | $1.5B | n/a |
Against its peers
Companies in Healthcare nearest Black Diamond Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| BDTXBlack Diamond Therapeutics | $108M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| APTAlpha Pro Tech | $56.7M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| Peer median | $147.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Black Diamond Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.